Eagle Pharmaceuticals
EGRX
#10505
Rank
โ‚ฌ2.43 M
Marketcap
0,19ย โ‚ฌ
Share price
46.67%
Change (1 day)
-67.59%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: โ‚ฌ2.43 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of โ‚ฌ2.43 Million. This makes Eagle Pharmaceuticals the world's 10505th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ2.43 M-64.5%
2024โ‚ฌ6.84 M-88.85%
2023โ‚ฌ61.44 M-82.68%
2022โ‚ฌ0.35 B-38.92%
2021โ‚ฌ0.58 B17.69%
2020โ‚ฌ0.49 B-32.51%
2019โ‚ฌ0.73 B49.18%
2018โ‚ฌ0.49 B-26.24%
2017โ‚ฌ0.66 B-43.09%
2016โ‚ฌ1.16 B-7.94%
2015โ‚ฌ1.26 B608.84%
2014โ‚ฌ0.17 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
โ‚ฌ2.43 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ424.03 B 17,440,775.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ84.51 B 3,476,203.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚ฌ222.64 B 9,157,677.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚ฌ29.69 B 1,221,308.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ150.34 B 6,183,679.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ819.14 B 33,692,065.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ94.08 B 3,869,588.03%๐Ÿ‡บ๐Ÿ‡ธ USA